BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 402829)

  • 21. Metal allergy to stainless steel wire after coronary artery bypass grafting.
    Takazawa K; Ishikawa N; Miyagawa H; Yamamoto T; Hariya A; Dohi S
    J Artif Organs; 2003; 6(1):71-2. PubMed ID: 14598128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of fibrinopeptide A generation tests in the evaluation and the monitoring of the action of heparin and its low molecular weight fractions.
    Emanuele RM; Fareed J; Hoppensteadt D; Walenga JM
    Semin Thromb Hemost; 1984 Oct; 10(4):243-51. PubMed ID: 6515419
    [No Abstract]   [Full Text] [Related]  

  • 23. Thrombogenicity of angiographic catheters.
    Wilner GD; Casarella WJ; Baier R; Fenoglio CM
    Circ Res; 1978 Sep; 43(3):424-8. PubMed ID: 150317
    [No Abstract]   [Full Text] [Related]  

  • 24. Thrombogenicity of arterial catheters and guidewires.
    Roberts GM; Roberts EE; Davies RL; Lawrie BW
    Br J Radiol; 1977 Jun; 50(594):415-8. PubMed ID: 871586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Benzalkonium-heparin-coated angiographic catheters. Experience with 563 patients.
    Hawkins IF; Kelley MJ
    Radiology; 1973 Dec; 109(3):589-91. PubMed ID: 4772171
    [No Abstract]   [Full Text] [Related]  

  • 26. Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation.
    Monnink SH; van Boven AJ; Peels HO; Tigchelaar I; de Kam PJ; Crijns HJ; van Oeveren W
    J Investig Med; 1999 Jul; 47(6):304-10. PubMed ID: 10431485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fibrinogen metabolism and plasma fibrinopeptide A in disseminated neoplasms].
    Mombelli G; Roux A; Hofmann V; Straub PW
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1901. PubMed ID: 531571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of blood flow and the effect of protamine on the thromboresistant properties of a covalently bonded heparin surface.
    Arnander C; Olsson P; Larm O
    J Biomed Mater Res; 1988 Oct; 22(10):859-68. PubMed ID: 3220839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibrinogen Zurich I: impaired release of fibrinopeptide A.
    Hofmann V; Gati WP; Straub PW
    Thromb Haemost; 1979 Jun; 41(4):709-13. PubMed ID: 483244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of fibrinopeptide A in human blood.
    Nossel HL; Yudelman I; Canfield RE; Butler VP; Spanondis K; Wilner GD; Qureshi GD
    J Clin Invest; 1974 Jul; 54(1):43-53. PubMed ID: 4600045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of fibrinopeptide A in surgery].
    Fuwa S
    Nihon Geka Gakkai Zasshi; 1984 Mar; 85(3):191-205. PubMed ID: 6236358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity.
    Nossel HL; Ti M; Kaplan KL; Spanondis K; Soland T; Butler VP
    J Clin Invest; 1976 Nov; 58(5):1136-44. PubMed ID: 993337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human tissue-type plasminogen activator releases fibrinopeptides A and B from fibrinogen.
    Weitz JI; Cruickshank MK; Thong B; Leslie B; Levine MN; Ginsberg J; Eckhardt T
    J Clin Invest; 1988 Nov; 82(5):1700-7. PubMed ID: 3141481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the thrombogenicity of commercially available catheters.
    Durst S; Leslie J; Moore R; Amplatz K
    Radiology; 1974 Dec; 113(3):599-600. PubMed ID: 4279417
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of surface texture and charge on the biocompatibility of endovascular stents.
    Hehrlein C; Zimmermann M; Metz J; Ensinger W; Kübler W
    Coron Artery Dis; 1995 Jul; 6(7):581-6. PubMed ID: 7582197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of a commercial kit for the radioimmunoassay of fibrinopeptide A.
    Butt RW; deBoer AC; Turpie AG
    J Immunoassay; 1984; 5(3-4):245-66. PubMed ID: 6530485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraperitoneal heparin in peritoneal dialysis and its effect on fibrinopeptide A in plasma and dialysate.
    Gries E; Paar D; Graben N; Bock KD
    Haemostasis; 1989; 19(1):21-5. PubMed ID: 2920976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Particle bounce in a personal cascade impactor: a field evaluation.
    Hinds WC; Liu WC; Froines JR
    Am Ind Hyg Assoc J; 1985 Sep; 46(9):517-23. PubMed ID: 4050689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.